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Objective: Genetic factor plays an important role in early failure of total hip arthroplasty (aseptic loosening)
etiology, and TIMP-1 gene may be involved. The present study was conducted to reveal possible association
between TIMP-1 polymorphisms with the risk of early failure of total hip arthroplasty (THA) (aseptic loosening).
Methods: The TIMP-1 single nucleotide polymorphisms (SNPs) rs4898, rs6609533, and rs2070584 were genotyped
in 59 subjects who were diagnosed as aseptic loosening after total hip arthroplasty and in 100 controls.
Results: The TIMP-1 SNP rs4898 T allele in the case group was found to be 1.32 fold (P = 0.0013, 95% CI = 1.16 to
1.58) than the control group. Similarly, the G allele of rs6609533 was found to be associated with increased risk of
aseptic loosening (OR = 1.78, 95% CI = 1.52 to 2.17, P < 0.0001). For SNP rs2070584, no statistical association was
found (A vs. G, OR = 1.14, 95% CI = 0.97 to 1.40, P = 0.2028).
Conclusion: The results showed that the TIMP-1 SNPs rs4898 and rs6609533 were associated with the increased risk
of early aseptic loosening susceptibility.
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There are numerous patients with end stage arthritis
treated with cemented total hip arthroplasty (THA), and
the number is rapidly increasing [1-4]. Almost 1 million
of THA are implanted worldwide annually, with a predict-
ing increase of 174% to nearly 600,000 THA procedures
annually by 2030 in the United States [5-7]. However, in-
dispensable proportion of patients after THA still faces
the complications that may lead to the premature pros-
thesis failure and revision surgery, with significant im-
pact on their quality of life [5]. While sepsis, fracture,
and dislocation are relatively rare, loosening of the total
hip prosthesis arising from aseptic inflammatory reac-
tions is one of the most critical phenomena (accounts
for 75.7% of all THA revisions) in the treatment of total
hip arthroplasty [8-10].* Correspondence: fypan_2014@163.com
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unless otherwise stated.The aseptic loosening after THA has been considered
to be due to both mechanical stress and local host re-
sponses to the implanted materials including the wear
debris of high density polyethylene, bone cement, and
metals; however, the precise biological mechanisms re-
sponsible for loosening have not yet been completely
clarified [11-14]. Nowadays, it is considered that the
prosthesis stimulates the inflammatory response of mes-
enchymal cells and accumulates the osteoclast, leading
to excessive resorption, bone loss, and eventually peri-
prosthetic osteolysis [15,16]. However, given the exist-
ence of the individual difference of susceptibility to
aseptic loosening, there may be a combination of envir-
onmental and genetic factors influencing the patholo-
gies. Environmental factors have been widely studied
across the world, including the implant design, material,
type of prosthesis, fixation method, surgical technique,
and postoperative rehabilitation procedure [17,18]. How-
ever, the individual susceptibility difference was mostly
related to the genetic factors like single nucleotide
polymorphisms (SNPs). Various gene SNPs of GNAS1,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ported to be associated with increased prosthetic loosening.
The release of implant particles and debris into the
periprosthetic tissues leads to the formation of reactive
granulation tissue against a foreign body, and it activates
the cells to produce cytokines and enzymes [19]. Previous
studies demonstrated that this granulomatous tissue has
the ability to produce inflammatory cytokines and sub-
stances, i.e., interleukin-1 (IL-1), platelet-derived growth
factor (PDGF), prostaglandin E2 (PGE2), etc. [20]. Matrix
metalloproteinases (MMPs) are a family of enzymes se-
creted by mesenchymal and haemopoietic cells that can
degrade various types of collagen, which is the most im-
portant component of the extracellular matrix (ECM).
They are active at neutral pH and are all inhibited by spe-
cific secreted inhibitors, tissue inhibitors of metallopro-
teinases (TIMPs). Recently, many studies acknowledged
that MMPs play an important role in the variety of tissue
destruction, i.e., metastatic tumor, rheumatoid arthritis,
and cartilage breakdown [21]. Numerous studies have
demonstrated that specific MMPs and TIMPs are ex-
pressed in the periprosthetic tissues and are critically in-
volved in the bone resorption and subsequent implant
failure [22-27]. SNPs of MMP1 have been related to in-
creased risk of prosthetic loosening. However, no genetic
research between TIMPs polymorphism and aseptic loos-
ening after THA has been performed so far. This study
aims to determine whether the TIMP-1 SNPs rs4898,
rs6609533, and rs2070584 were associated with failure of
THA (aseptic loosening) in Chinese Han population.
Method
The study was approved by the ethics committee of the
Chinese People’s Liberation Army 107 Hospital, and in-
formed consent was obtained from patients and control
participants.
Study population
Fifty-nine patients diagnosed with aseptic loosening after
total hip arthroplasty at the Department of Orthopaedics
of Chinese People’s Liberation Army 107 Hospital were
enrolled in this study. All the patients were diagnosed
based on the findings of clinical, radiological, laboratory,
and intra-surgical changes. The diagnosis criteria of
aseptic loosening were documented as follows: 1. Clin-
ical symptoms like hip pain during walking or moving
the joint. 2. Radiological changes like migration of pros-
thetic or bone radiolucency around the prosthesis of
more than 2 mm. 3. Abnormal laboratory data like
erythrocyte sedimentation rate and leukogram. Patients
were excluded if they had any deep infection or the sus-
picion of implant infection, inflammatory diseases, trau-
matic loosening, or immunosuppressant agents after
THA in their history. Also, aseptic loosening developedafter 10 years since THA was excluded from this study.
The control group consists of 100 age- and gender-
matched patients who had undergone THA that had
been seen to be therapeutically successful over long-
term follow-up. All subjects included in this study were
Chinese Han population.
Genotyping
DNA samples were obtained from all the participants
from peripheral blood with the Chelex 100 method [28].
The primers and probes were designed and synthesized
by Sigma (Sigma-Proligo, The Woodlands, TX). The
SNPs were genotyped using Taqman assay (Applied Bio-
systems 7500, ABI, Foster City, CA) and dual-labeled
probes in real-time PCR. Genotyping was performed by
an independent laboratory personnel, and two authors
independently reviewed the results. Disagreements were
resolved through a discussion and consensus. In addition,
5% samples of the case and control subjects were ran-
domly selected for reproducibility tests at least twice to
yield a 100% concordant.
Statistical analysis
Statistical Package for Social Sciences software (SPSS
Inc., Chicago, IL, USA), version 16.0 for Windows and
HaploView software were used for statistical analysis in
this study. The demographic and clinical data were pre-
sented as mean ± SD and compared between groups by
the student’s t tests. The genotype and allelic frequencies
were evaluated by Hardy–Weinberg equilibrium and
compared by the Chi-square test. Multivariate logistic
regression was used to estimate odds ratios (ORs) and
95% confidence intervals (CI) after adjustment for age,
gender, and body mass index (BMI). The linkage dis-
equilibrium (LD) mapping and the associations between
haplotypes of selected SNPs and risk of aseptic loosening
after THA were estimated by HaploView software. The




Demographic data of the subjects enrolled were shown
in Table 1. There were no significant differences between
groups in respect to the age, gender, and BMI. The mean
period after THA was 8.2 ± 1.5 years when the aseptic
loosening happened, and the control group has a mean
period of 12.7 ± 2.3 years after THA.
Association of TIMP-1 polymorphisms with susceptibility
to failure of THA
As expected, the distribution of the genotypes of SNPs
of TIMP-1 gene conformed to the Hardy–Weinberg
equilibrium and the genotyping success rate was 100%.
Table 1 The summary of the basic characteristics of the
groups




Age (years) 68.6 ± 8.4 70.3 ± 7.1 n.s
Female/male 22/37 36/64 n.s
BMI (kg/m2) 27.4 ± 5.9 26.9 ± 6.6 n.s
Mean time after THA (years) 8.2 ± 1.5 12.7 ± 2.3 <0.001
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the three SNPs for the cases and controls. The TIMP-1
SNPs rs4898 and rs6609533 were found to be signifi-
cantly associated with an increased risk of THA failure
after adjustment of age, gender, and BMI. The TIMP-1
SNP rs4898 T allele in the case group was found to be
1.32 fold (P = 0.0013, 95% CI = 1.16 to 1.58) than the
control group. Similarly, the G allele of rs6609533 was
found to be associated with an increased risk of aseptic
loosening (OR = 1.78, 95% CI = 1.52 to 2.17, P < 0.0001).
For SNP rs2070584, no statistical association was found
(A vs. G, OR = 1.14, 95% CI = 0.97 to 1.40, P = 0.2028).
The LD within TIMP-1 gene was only found between
rs4898 and rs6609533, showing that these two polymor-
phisms belong to one haploblock (Figure 1).Discussion
This is the first study investigating the possible role of
TIMP-1 SNPs in the pathologies of aseptic loosening of
the total hip prosthesis. The present study revealed the
association between TIMP-1 SNPs rs4898 and rs6609533
with the increased risk of early failure of THA (aseptic
loosening).Table 2 The genotype and allele distributions of the three
SNPs for the cases and controls
Group rs4898 Genotype Allele (%)
CC CT TT C T OR (95%CI)a Pa
Control 36 45 19 58.5 41.5 1.32 (1.16 to 1.58) 0.0013
Case 16 29 14 51.7 48.3
Group rs6609533 Genotype Allele (%)
TT TG GG T G OR (95%CI)a Pa
Control 45 37 18 63.5 36.5 1.78 (1.52 to 2.17) < 0.0001
Case 13 32 14 49.2 50.8
Group rs2070584 Genotype Allele (%)
GG AG AA G A OR (95%CI)a Pa
Control 49 40 11 69.0 31.0 1.14 (0.97 to 1.40) 0.2028
Case 27 24 8 66.1 33.9
aORs and 95% CIs were estimated using multiple logistic regression analyses
and adjusted for age, gender, and BMI.
Figure 1 The LD across the TIMP-1 gene. The results of LD
mapping are generated using Haploview software. The values for D’
between each SNP are presented in each box.Although total hip arthroplasty is a mature and suc-
cessful surgery that improves the quality of life signifi-
cantly, it cannot be ignored that there are still many
patients suffering from early failure of the THA. Import-
antly, aseptic loosening due to the periprosthetic oste-
olysis is known to be the main reason for an early failure
after THA.
Although many reports have been published on the
pathogenesis of periprosthetic loosening, the precise bio-
logical mechanisms responsible for this process have not
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logical, biomechanical factors, etc. have been considered
to introduce the aseptic loosening. However, the abnormal
immunological responses caused by the wear-generated
particular debris surrounding the implant components
were considered as the core of the pathologies [29,30].
The periprosthetic loosening and osteolysis were found to
be correlated with higher wear rates of the prosthesis [29].
The experimental systems also demonstrated that particu-
late debris could induce osteolysis in a variety of animal
models and inflammatory responses in cultured macro-
phages [31,32]. The release of particles induced an
immunological response which is taking place in the cap-
sular tissue initially. The macrophages, osteoclasts, fibro-
blasts, etc. were activated and produced various chemical
factors and mediators [17,33-36]. These soluble factors
migrate in the interface between the implant and the bone,
where they continue the immune response but mainly af-
fected the bone tissues.
ECM degradation and connective tissue remodeling
around implants have been considered as major bio-
logical events in the periprosthetic loosening. Among
which the MMPs and TIMPs play as critical mediators
of wear particle-induced inflammatory osteolysis. MMP
is one of the cytokines and lipid mediators that increases
the destruction of the extracellular organic matrix of
bone [22,23,37-39]. The expression of MMP-13 was
found in the macrophages, endothelial cells, and fibro-
blasts of the synovial-like membrane around the implant
[35]. Local messenger RNA (mRNA) expression profile
also showed that MMP-1, MMP-9, MMP-10, MMP-12,
and MMP-13 were strongly elevated in aseptic loosening
compared to controls. Furthermore, collagen degrad-
ation in periprosthetic tissue correlated significantly with
the number of local MMP-1 and MMP-13 [36]. Re-
cently, Malik and coworkers reported the association of
a MMP-1 SNP rs5854 and the occurrence of increased
aseptic loosening susceptibility [40]. The proteolytic ac-
tivity of MMPs is regulated by specific TIMPs. The bal-
ance between the levels of activated MMPs and free
TIMPs determines in part the net MMP activity. In
addition to regulating the MMPs, TIMPs have also been
shown to have angiogenic and growth factor-like activ-
ities [41]. Quantitative analysis of mRNA expression of
TIMPs in periprosthetic tissues showed a significant up-
regulation of TIMP-1, TIMP-2, and TIMP-3 in contrast
to the decreased levels of TIMP-4 [25]. The strong ex-
pression of TIMP-2 in the interface tissue around im-
plants was also reported by Ishiguro and coworkers [26].
The most important limitation of the present study is
the relatively small sample size. A single center case–
control study is not sufficient to fully interpret the rela-
tionship between TIMP-1 polymorphisms and the risk
of early failure of THA (aseptic loosening). Further studywith multiple center and larger sample size is needed.
Also, our investigation is only a genetic association
study, and the precise impact of this polymorphism on
protein function has not been confirmed by molecular
biology techniques.
Conclusions
The present study was conducted to reveal possible as-
sociation between TIMP-1 SNPs with the risk of early
failure of THA (aseptic loosening). The results showed
that the TIMP-1 SNPs rs4898 and rs6609533 were asso-
ciated with the increased risk of early aseptic loosening
susceptibility.
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